These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19816072)

  • 21. Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.
    Antón A; Barnadas A; Florián J; Ribelles N; Lomas M; Lao J; González-Quintás A; Margelí M; Paules AB; Gayo J; Ramos M;
    Clin Transl Oncol; 2011 Apr; 13(4):281-6. PubMed ID: 21493190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.
    Fumoleau P; Déporte-Fety R; Kerbrat P; Laguerre B
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):86-90. PubMed ID: 10442371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.
    Lin PH; Lu YS; Lin CH; Chang DY; Huang CS; Cheng AL; Yeh KH
    Anticancer Res; 2010 Jul; 30(7):3087-91. PubMed ID: 20683060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral vinorelbine in metastatic breast cancer: a review of current clinical trial results.
    Aapro M; Finek J
    Cancer Treat Rev; 2012 Apr; 38(2):120-6. PubMed ID: 21742438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.
    Urien S; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Deporte-Fety R
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):99-107. PubMed ID: 12768319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy.
    Fumoleau P; Cortés-Funes H; Taleb AB; Chan S; Campone M; Pouget JC; Tubiana-Hulin M; Slabber CF; Caroff-Paraïso I; Alberts AS; Ben Ayed F
    Am J Clin Oncol; 2009 Aug; 32(4):375-80. PubMed ID: 19487917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study.
    Oliva C; Bergnolo P; Inguì M; Bianco L; Pochettino P; Cutin SC; Boglione A; Dal Canton O; Garetto F; Comandone A
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):411-7. PubMed ID: 19727815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies.
    Lorusso V; Cinieri S; Giampaglia M; Ciccarese M; Tinelli A; Chiuri V; Manca C; Silvestris N; Gasparini G; Colucci G
    Breast; 2010 Jun; 19(3):214-8. PubMed ID: 20167491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uracil/tegafur plus oral calcium folinate in advanced breast cancer.
    Richardet E; Pedraza C; Mickiewicz E; Lerzo G; Bonamasa M; Coppola F; Elli A; Uranga G; Jovtis S; Bruno M; Ventriglia M; Cuevas MA; Alvarez AM; Suarez LA; Fein L
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):96-7. PubMed ID: 10442373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer.
    Seo HY; Lee HJ; Woo OH; Park KH; Woo SU; Yang DS; Kim AR; Lee JB; Lee ES; Kim YH; Kim JS; Seo JH
    Invest New Drugs; 2011 Apr; 29(2):360-5. PubMed ID: 19943080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
    Martin M; Casado A; López-Martin JA; Rodriguez-Lescure A; Nieto Y; Ayala F; Diaz-Rubio E
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):83-5. PubMed ID: 9348575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
    Lück HJ; Scholz U; Kühnle H; Dethling J
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epirubicin, cyclophosphamide, and UFT plus oral calcium folinate in advanced breast cancer.
    Smith IE
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):82-5. PubMed ID: 10442370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between Ki67 expression and tumor response to neoadjuvant chemotherapy with anthracyclines plus taxanes in breast cancer].
    Xu L; Liu YH; Ye JM; Zhao JX; Duan XN; Zhang LB; Zhang H; Wang YH
    Zhonghua Wai Ke Za Zhi; 2010 Mar; 48(6):450-3. PubMed ID: 20627009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects and toxicity of neoadjuvant chemotherapy with vinorelbine and cisplatin in treatment of operable breast cancer previously non-responsive to anthracyclines and taxanes-containing regimen: analysis of 19 cases].
    Xu L; Ye JM; Zhao JX; Duan XN; Liu YH
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):683-5. PubMed ID: 19595063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer.
    Solé LA; Albanell J; Bellmunt J; Ribas A; Gallego OS; Carulla J
    Cancer; 1995 Feb; 75(3):831-5. PubMed ID: 7828134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate, uracil and tegafur, and leucovorin chemotherapy for patients with breast cancer in progression after high-dose chemotherapy with peripheral blood progenitor cell transplant: a phase II study.
    Martín M; Casado A; Macias JA; Garcia-Carbonero I; Garcia-Saenz JA; Oruezabal M; Manrique I; Diaz-Rubio E
    Am J Clin Oncol; 2000 Dec; 23(6):617-21. PubMed ID: 11202810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane.
    Grenader T
    Onkologie; 2012; 35(1-2):24-6. PubMed ID: 22310341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer.
    Rossi D; Baldelli AM; Catalano V; Casadei V; Alessandroni P; Giordani P; Graziano F; Fedeli SL
    Breast Cancer; 2012 Jul; 19(3):275-7. PubMed ID: 19756926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer.
    Alonso V; Santader C; Florian J; Alonso M; Isla MD; Escudero P; Saenz A; Tres A
    Tumori; 1996; 82(1):61-4. PubMed ID: 8623508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.